Search results for "Renal function"

showing 10 items of 381 documents

Effects of the flavonoids extracted from Spergularia purpurea Pers. on arterial blood pressure and renal function in normal and hypertensive rats

2001

The antihypertensive and diuretic effects of the flavonoids extracted from Spergularia purpurea Pers. (SP) were studied both in normotensive (NTR) and spontaneously hypertensive conscious rats (SHR). Daily oral administration of the flavonoid mixture (5 mg/kg for 1 week) exhibited a significant decrease in blood pressure with variation coefficient (Delta) of 20 in SHR rats and 11 in NTR rats. The systolic and diastolic blood pressure decreased significantly and respectively with 17 and 24% in SHR, and with 11 and 16% in NTR. The flavonoid mixture enhanced significantly the water excretion in hypertensive (P<0.001) and normal rats (P<0.001). Furthermore, oral administration of flavonoids mix…

Malemedicine.medical_specialtyUrinary systemmedicine.medical_treatmentAdministration OralRenal functionBlood PressureKidneyKidney Function Testslaw.inventionOral administrationlawRats Inbred SHRInternal medicineDrug DiscoveryHeart ratemedicineAnimalsRats WistarDiureticsAntihypertensive AgentsFlavonoidsPharmacologybiologyPlant Extractsbusiness.industryfood and beveragesbiology.organism_classificationRatsBlood pressureEndocrinologyHypertensionDiureticPhytotherapybusinessSpergulariaJournal of Ethnopharmacology
researchProduct

Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensiv…

2018

Obesity is a well‐known risk factor for the development and progression of chronic kidney disease. Recently, para‐perirenal ultrasonographic fat thickness (PUFT) has shown to correlate with both total and visceral fat better than body mass index (BMI), waist circumference (WC), and other indices of obesity. Moreover, a local paracrine and mechanical action of the PUFT on kidney has been described in recent studies. Aim of our study was to assess the relationship between glomerular filtration rate (GFR) and PUFT in comparison with other anthropometric and ultrasonographic indices of adiposity. Two hundred and ninety‐six hypertensive patients were enrolled. PUFT, cutis‐rectis thickness and re…

Malemedicine.medical_specialtyWaisthypertensionEndocrinology Diabetes and Metabolism030232 urology & nephrologyUrologyRenal functionrenal damageIntra-Abdominal Fat030204 cardiovascular system & hematologyadiposity; glomerular filtration rate; hypertension; para-perirenal fat thickness; renal damage; Internal Medicine; Endocrinology Diabetes and Metabolism; Cardiology and Cardiovascular MedicineBody Mass Index03 medical and health sciencesEndocrinology0302 clinical medicinePredictive Value of TestsRisk Factorspara-perirenal fat thicknemedicineInternal MedicineBody Fat DistributionHumansRenal Insufficiency ChronicRisk factorAgedUltrasonographyadiposityglomerular filtration rateAnthropometryReceiver operating characteristicbusiness.industrypara-perirenal fat thicknessConfoundingArea under the curveMiddle Agedmedicine.diseaseDiabetes and MetabolismCross-Sectional StudiesHypertension and ObesityFemaleWaist CircumferencebusinessCardiology and Cardiovascular MedicineBody mass indexKidney disease
researchProduct

Risk Factors of Coronary Artery Disease in Secondary Prevention—Results from the AtheroGene—Study

2015

Background Risk factors are important in cardiovascular (CV) medicine for risk stratification of patients. We aimed to compare the traditional risk factors to clinical variables for the prediction of secondary cardiovascular events. Methods and Results For this study, 3229 patients with known coronary artery disease (CAD) were included. We calculated whether the traditional risk factors, diabetes mellitus, increased LDL/HDL ratio, arterial hypertension and smoking alone and in combination with the clinical variables, ejection fraction, creatinine clearance, multi-vessel disease and CRP concentration predict the outcome cardiovascular death or non-fatal myocardial infarction (N = 432) during…

Malemedicine.medical_specialtylcsh:MedicineRenal functionCoronary Artery DiseaseCoronary artery diseaseAnginaCohort StudiesRisk FactorsInternal medicineDiabetes mellitusmedicineSecondary PreventionHumansMyocardial infarctionRisk factorlcsh:ScienceProportional Hazards ModelsMultidisciplinarybusiness.industrylcsh:RHazard ratioMiddle Agedmedicine.diseaseCardiologyRegression Analysislcsh:QFemalebusinessCohort studyResearch ArticleFollow-Up StudiesPLoS ONE
researchProduct

Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization …

2012

Recent observations in chronic stable heart failure suggest that high-dose loop diuretics (HDLDs) have detrimental prognostic effects in patients with high blood urea nitrogen (BUN), but recent findings have also indicated that diure- tics may improve renal function. Carbohydrate antigen 125 (CA125) has been shown to be a surrogate of systemic congestion. We sought to explore whether BUN and CA125 modulate the mortality risk associated with HDLDs following a hospitalization for acute heart failure (AHF). Methods and results We analysed 1389 consecutive patients discharged for AHF. CA125 and BUN were measured at a mean of 72+12 h after admission. HDLDs (≥120 mg/day in furosemide equivalent d…

Malemedicine.medical_specialtymedicine.drug_classRenal functionGastroenterologyRisk AssessmentLoop diureticsBlood Urea NitrogenCohort StudiesSodium Potassium Chloride Symporter InhibitorsFurosemideInternal medicinemedicineHumansProspective StudiesMortalityProspective cohort studyBlood urea nitrogenAgedAged 80 and overHeart Failurebusiness.industryHazard ratioFurosemideAcute heart failureLoop diureticMiddle Agedmedicine.diseaseConfidence intervalfemale genital diseases and pregnancy complicationsHospitalizationBlood urea nitrogenEndocrinologyCarbohydrate antigen 125Heart failureCA-125 AntigenAcute DiseaseFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugFollow-Up StudiesEuropean journal of heart failure
researchProduct

Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart …

2014

The use of loop diuretics in acute heart failure (AHF) is largely empirical and has been associated with renal function impairment by reducing renal perfusion but also renal improvement by decreasing renal venous congestion. Antigen carbohydrate 125 (CA125) has emerged as a proxy for fluid overload. We sought to evaluate whether the early changes in creatinine (ΔCr) induced by intravenous furosemide doses (ivFD) differ among clinical groups defined by overload status (CA125) and creatinine on admission (Cr).We included 526 consecutive patients admitted for AHF. All patients received intravenous furosemide for the first 48 hours. CA125 and Cr were dichotomized at 35 U/ml and 1.4 mg/dl, respe…

Malemedicine.medical_specialtymedicine.drug_classUrologyRenal functionKidneyCohort Studieschemistry.chemical_compoundPatient AdmissionAntigenSodium Potassium Chloride Symporter InhibitorsPredictive Value of TestsInternal medicinemedicineHumansIn patientInfusions IntravenousAgedAged 80 and overHeart FailureCreatininebusiness.industryFurosemideCarbohydrateLoop diureticMiddle Agedmedicine.diseaseEndocrinologychemistryHeart failureCA-125 AntigenCreatinineAcute DiseaseFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugFollow-Up StudiesInternational journal of cardiology
researchProduct

Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure.

2012

Aims Continuous ambulatory peritoneal dialysis (CAPD) has been proposed as an additional therapeutic resource for patients with advanced congestive heart failure (CHF). The objective of this study was to determine the therapeutic role of CAPD, in terms of surrogate endpoints, in the management of patients with advanced CHF and renal dysfunction. A total of 57 candidates with New York Heart Association (NYHA) class III/IV CHF, renal dysfunction (glomerular filtration rate , 60 mL/min/1.73 m 2 ), persistent fluid congestion despite loop diuretic treatment, and at least two previous hospitalizations for acute heart failure (AHF) were invited to be included in the CAPD programme; however, 25 pa…

Malemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentRenal functionurologic and male genital diseasesKidneySeverity of Illness IndexPeritoneal dialysisPeritoneal Dialysis Continuous AmbulatoryInternal medicineSurveys and QuestionnairesmedicineAmbulatory CareHumanscardiovascular diseasesProspective StudiesRenal InsufficiencyProspective cohort studyHeart Failurebusiness.industrySurrogate endpointContinuous ambulatory peritoneal dialysisLoop diureticBrain natriuretic peptidemedicine.diseaseHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersGlomerular Filtration RateEuropean journal of heart failure
researchProduct

Prevalence of Uncontrolled Hypertension in Patients With Fabry Disease

2017

Background Fabry disease is a rare X-linked disease arising from deficiency of α-galactosidase A. It results in early death related to renal, cardiac, and cerebrovascular disease, which are also important outcomes in patients with elevated blood pressure (BP). The prevalence of uncontrolled hypertension, as well as the effect of enzyme replacement therapy on BP, in patients with Fabry disease is unknown. Methods We examined uncontrolled hypertension (systolic BP [SBP] ≥130 mm Hg or diastolic BP [DBP] ≥80 mm Hg) among 391 patients with Fabry disease who were participating in the Fabry Outcome Survey (FOS). Results Uncontrolled hypertension was present in 57% of men and 47% of women. In patie…

Malemedicine.medical_specialtymedicine.medical_treatmentDiastoleRenal functionBlood PressureKidneyInternal medicinePrevalenceInternal MedicinemedicineHumansSex Ratiocardiovascular diseasesAntihypertensive AgentsKidney transplantationDialysisbusiness.industryEnzyme replacement therapymedicine.diseaseKidney TransplantationFabry diseaseSurgeryBlood pressureHypertensionCardiologyFabry DiseaseFemalebusinessDialysiscirculatory and respiratory physiologyKidney diseaseAmerican Journal of Hypertension
researchProduct

Use of acetazolamide in the treatment of patients with refractory congestive heart failure

2018

Aims Optimal diuretic treatment of patients with refractory congestive heart failure (CHF) remains to be elucidated. In this work, we aimed to evaluate the serial changes of functional class and surrogates of fluid overload (weight and antigen carbohydrate 125) after addition of oral acetazolamide in patients with refractory CHF. Likewise, serial changes in renal function, serum electrolytes and pH were evaluated. Method This is an observational retrospective study in which 25 ambulatory patients with refractory CHF that received acetazolamide in addition to standard intensive diuretic strategy were evaluated. Longitudinal assessment of New York Heart Association (NYHA) functional class and…

Malemedicine.medical_treatmentAdministration Oral030204 cardiovascular system & hematology0302 clinical medicineNatriuretic peptidePharmacology (medical)030212 general & internal medicineDiureticsfluid overloadAged 80 and overcongestionGeneral MedicineWater-Electrolyte BalanceTreatment OutcomeCardiologyFemaleCardiology and Cardiovascular MedicineAcetazolamideGlomerular Filtration Ratemedicine.drugmedicine.medical_specialtymedicine.drug_classRenal function03 medical and health sciencesRefractoryInternal medicineWeight LossmedicineHumansAgedRetrospective StudiesHeart FailurePharmacologybusiness.industryRetrospective cohort studyRecovery of Functionmedicine.diseasediureticsAcetazolamideacetazolamideBlood pressureCA-125 AntigenHeart failureFeasibility Studiesrefractory congestive heart failureDiureticbusinessBiomarkersfeasibilityCardiovascular Therapeutics
researchProduct

Survival outcomes in patients with large (≥7cm) clear cell renal cell carcinomas treated with nephron-sparing surgery versus radical nephrectomy: Res…

2018

Background Does the dogma of nephron sparing surgery (NSS) still stand for large renal masses? Available studies dealing with that issue are considerably biased often mixing imperative with elective indications for NSS and also including less malignant variants or even benign renal tumors. Here, we analyzed the oncological long-term outcomes of patients undergoing elective NSS or radical tumor nephrectomy (RN) for non-endophytic, large (≥7cm) clear cell renal carcinoma (ccRCC). Methods Prospectively acquired, clinical databases from two academic high-volume centers were screened for patients from 1980 to 2010. The query was strictly limited to patients with elective indications. Surgical co…

Malemedicine.medical_treatmentCancer Treatment030232 urology & nephrologylcsh:MedicineKaplan-Meier EstimateNephrectomyCohort StudiesMathematical and Statistical Techniques0302 clinical medicineRisk FactorsSurgical oncologyGermanyMedicine and Health SciencesMedicineRadical Nephrectomylcsh:ScienceAged 80 and overMultidisciplinaryMiddle AgedKidney NeoplasmsNephrectomySurgical OncologyOncologyNephrologyResearch DesignRenal Cancer030220 oncology & carcinogenesisPhysical SciencesFemaleAnatomyStatistics (Mathematics)Research ArticleCohort studyClinical OncologyAdultmedicine.medical_specialtyClinical Research DesignUrologyRenal functionSurgical and Invasive Medical ProceduresResearch and Analysis MethodsUrinary System Procedures03 medical and health sciencesCarcinomaHumansStatistical MethodsCarcinoma Renal CellSurvival analysisAgedRetrospective StudiesSurgical Excisionbusiness.industrylcsh:RBiology and Life SciencesKidneysRetrospective cohort studyRenal SystemNephronsmedicine.diseaseSurvival Analysislcsh:QClinical MedicinebusinessComplicationMathematicsFollow-Up StudiesPLOS ONE
researchProduct

Early serum creatinine changes and outcomes in patients admitted for acute heart failure: the cardio-renal syndrome revisited.

2017

Background: The changes in renal function that occurred in patients with acute decompensated heart failure (ADHF) are prevalent, and have multifactorial etiology and dissimilar prognosis. To what extent the prognostic role of such changes may vary according to the presence of renal insufficiency at admission is not clear. Accordingly, we sought to determine whether early creatinine changes (Cr) (admission to 48-72 hours) had an effect on 1-year mortality relative to the presence of renal insufficiency at admission. Methods: We included 705 consecutive patients admitted with the diagnosis of ADHF. Admission renal insufficiency was defined as serum creatinine 1.4mg/dl (A-RIcr) or estimated gl…

Malerenal failureTime FactorsAcute decompensated heart failure030204 cardiovascular system & hematologyCritical Care and Intensive Care Medicinechemistry.chemical_compound0302 clinical medicineCardio-Renal SyndromeRisk FactorsCause of DeathPrevalenceMedicine030212 general & internal medicineHospital Mortalityskin and connective tissue diseasesKidneyGeneral MedicinePrognosisSurvival Ratemedicine.anatomical_structureabsolute creatinine changesCreatinineAcute DiseaseCardiologyFemaleCardiology and Cardiovascular Medicinemedicine.medical_specialtyacute decompensated heart failureRenal functionRisk Assessment03 medical and health sciencesInternal medicineHumansIn patientIntensive care medicineAgedRetrospective StudiesHeart FailureCreatinineInpatientsabsolute creatinine changes acute decompensated heart failure mortality renal failure worsening renal functionCardio-Renal Syndromebusiness.industrymedicine.diseasemortalitychemistrySpainHeart failureworsening renal functionEtiologysense organsbusinessBiomarkersFollow-Up Studies
researchProduct